 SAN DIEGO, Nov. 23, 2020 GLOBE NEWSWIRE -- Metacrine, Inc. Nasdaq: MTCR, a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases, today announced that Preston Klassen, M.D., MHS, president and chief executive officer of Metacrine, will present at the following December investor conferences: 